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ABSTRACT We report the complete genome sequence of a colistin-resistant strain
of uropathogenic Escherichia coli, isolated in January 2013 at King Abdulaziz Medical
City (KAMC), Riyadh, Saudi Arabia. The isolate (named SA186) was sequence type
131 (ST131) and belonged to serotype O25b-H4 and clade B (fimH22).
In response to the emergence of the plasmid-mediated colistin resistance gene mcr-1,first reported in China (1), retrospective PCR screening of a surveillance collection of
uropathogenic Escherichia coli (UPEC) isolates from King Abdulaziz Medical City (KAMC)
in Saudi Arabia identified a positive isolate belonging to the globally disseminated
sequence type 131 (ST131) clone (2). ST131 is an established high-risk clone causing
community-acquired and hospital-acquired urinary tract and bloodstream infections
and is a major public health concern (3, 4).
We determined the complete genome sequence of the mcr-1-positive ST131-O25:H4-
fimH22 clade UPEC isolate SA186, which was isolated from a 2-year-old female patient with
urinary tract infection in January 2013. Susceptibility testing performed using the Vitek II XL
system (bioMérieux, France) showed that SA186 was resistant to ampicillin (MIC, 32 mg/
liter), piperacillin (MIC, 128 mg/liter), gentamicin (MIC, 16 mg/liter), tobramycin (MIC,
8 mg/liter), norfloxacin (MIC, 2 mg/liter), and trimethoprim (MIC, 320 mg/liter) but sus-
ceptible to third-generation cephalosporins and carbapenems. SA186 resistance to colistin
(MIC, 8 mg/liter) was confirmed by the microbroth dilution method in accordance with the
Clinical and Laboratory Standards Institute (CLSI) (5).
The isolate was grown on Columbia agar (Oxoid) at 37°C, and genomic DNA was
extracted from an overnight single starting colony culture using the QIAsymphony SP
instrument following the manufacturer’s instructions (Qiagen). Genomic DNA (50 kb)
was sheared by passage through a 26-gauge needle, and the size of the fragments thus
generated (30 kb) was checked on a fragment analyzer. Fragmented DNA cleaned
with Ampure XP beads (Agencourt) was used for library preparation using the SMRTbell
template prep kit version 1.0 (PacBio) according to the manufacturer’s instructions. The
complete genome sequence of SA186 was determined using the PacBio RS II single-
molecule real-time (SMRT) instrument at the Centre for Genomic Research at the
University of Liverpool (United Kingdom).
PacBio sequence reads were assembled following the Hierarchical Genome Assem-
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bly Process (HGAP) workflow version 2.3.0 with the default settings (6). Briefly, high-
quality reads were first filtered and corrected by mapping single-pass reads to the
longest reads to generate highly accurate preassembled reads which were later assem-
bled into contigs using Celera Assembler version 8.1 and were further polished with
Quiver. Overlapping sequences at the ends were trimmed manually using CLC Main
Workbench version 6.9.1 (Qiagen Bioinformatics) to circularize the assembled contigs.
The accuracy of the contigs thus generated was confirmed with the assembly gener-
ated by Canu software version 1.0 (7). The assembly generated six contigs using a total
of 78,196 reads (number of bases, 1,287,850,329; mean read length, 16,469 bp) with an
average sequencing coverage depth of 185.73. The NCBI Prokaryotic Genome Anno-
tation Pipeline was used for coding sequence detection and annotation (8).
The genome of SA186 consisted of one 4,828,837-bp chromosome with a GC
content of 50.68% and five plasmids designated pSA186-MCR-1 (241,600 bp, 46.24% GC
content), pSA186-2 (198,748 bp, 49.36% GC content), pSA186-3 (113,162 bp, 50.66%
GC content), pSA186-4 (96,658 bp, 48.11% GC content), and pSA186-5 (106.936 bp,
48.88% GC content). Plasmid pSA186-MCR-1 carried the mcr-1 gene and belonged to
the incompatibility group IncHI2 and plasmid multilocus sequence typing (pMLST)
subtype ST4 (9). Identification of antibiotic resistance genes was performed using
ResFinder version 2.1 (10) and the Comprehensive Antimicrobial Resistance Database
(CARD) (11). It coharbored genes encoding resistance to aminoglycosides (aadA1,
aadA2, aphA1, strA, strB), penicillins (blaTEM-1B), macrolides (mphA, mefB), chloramphen-
icol (cml, floR), streptothricin (sat1), sulfonamides (sul3), tetracyclines [tet(A)], and
trimethoprim (dfrA14) and shared 99% nucleotide identity with IncHI2 plasmid pSA26-
MCR-1 (GenBank accession no. KU743384), which was previously described in a strain
of E. coli (ST68) isolated from a patient in Saudi Arabia in June 2012 (12). Plasmid
pSA186-MCR-1 was also highly similar (90% nucleotide identity) to mcr-1-positive
plasmids pS38 (GenBank accession no. KX129782) (13), p14408_M1 (GenBank accession
no. LT599829) (14), and pHNSHP45-2 (GenBank accession no. KP347127) (1), which were
recovered from human and animal E. coli isolates belonging to ST602 (Switzerland),
ST362 (Germany), and an undetermined ST (China), respectively.
In summary, this is the first report of a complete genome sequence of a multiresistant
ST131 fimH22 subclone non-extended-spectrum -lactamase (non-ESBL)/carbapenemase-
producing UPEC strain from Saudi Arabia, which harbors the mcr-1 gene. Its detection
highlights a new challenge in the emergence and evolution of antimicrobial resistance
plasmids in the Arabian Peninsula.
Data availability. The complete genome sequence of UPEC isolate SA186 has been
deposited in GenBank under the accession no. CP022730 for the chromosome, CP022731
for pSA186_2, CP022732 for pSA186_3, CP022733 for pSA186_4, CP022734 for
pSA186_5, and CP022735 for pSA186_MCR. These sequences are part of BioProject no.
PRJNA395653, and the SRA accession number is SRX3097879.
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